Staff Reporter
Published:
Digital migraine treatment devices market to hit $298.7m by 2030
Hospitals remained the leading end-user in 2024.
The global digital migraine treatment devices market is projected to reach $298.7m by 2030 at a compound annual growth rate of 16.46%, according to a DataM Intelligence report.
The sector’s expansion is attributed to the rising demand for drug-free, personalised, and wearable neuromodulation devices.
Hospitals remained the leading end-user in 2024, generating revenues of over $55m.
“Unlike conventional pharmaceuticals, digital migraine devices promise fewer side effects, real-time monitoring, and better patient adherence,” the report said.
Read Here
Advertise
Sign Up
